Skip to main content
. 2022 Jan 18;33:77–82. doi: 10.1016/j.ctro.2021.12.001

Table 4.

Symptoms and response.

High-dose Low-dose Sig.
No. patients with Pruritis (%)
Total 17 (54.8) 14 (70.0) 0.275
Improvement after TSEBT 11 (64.7) 9 (64.3)
No. patients with Pain (%)
Total 11 (35.5) 6 (30.0) 0.684
Improvement after TSEBT 6 (54.5) 3 (50.0)
No. patients with Ulcer (%)
Total 12 (38.7) 2 (10.0) 0.018
Improvement after TSEBT 8 (66.7) 0 (0.0)
Overall Respons after TSEBT (%)
No symtpom response 7 (26.9) 4 (28.6) 1.000
Respone of ≥ 1 symptom(s) 19 (73.1) 10 (71.4)